To determine if increased nuclear localization of EGR1 leads to changes in the expression of genes it regulates in EBV-positive cells, we considered candidates identified previously by ChIP-on-ChIP assays performed in prostate tumor cells (Arora et al., 2008). Here, EGR1 is linked to prostate neoplasm.